USFDA conducts inspection at Alembic Pharma’s Karkhadi Facility

21 Jan 2020 Evaluate

US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals API Facility located at Karkhadi from January 13, 2020 to January 17, 2020. This was a scheduled pre-approval inspection and at the end of the inspection, the USFDA issued a Form 483 with two observations.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

764.85 -5.35 (-0.69%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×